Every year during World Immunization Week we take the time to celebrate the impact of vaccines, but this year there is heightened concern and apprehension around the status of vaccination programs around the world. The big catch-up year Recent pandemic disruptions to health and education systems have led to significant drops in childhood vaccination numbers,...
Read more
On 17 April, IFPMA delivered a statement at the third meeting of the Working Group on Amendments to the International Health Regulations (2005) held from 17-20 April 2023.
Read moreCEOs met with Japanese Prime Minister Fumio Kishida and other officials in Japan, presenting the Tokyo Statement, which outlined top priorities for addressing global health challenges. They also discussed the importance to strengthen the innovation ecosystem in Japan and proposed establishing a strategic dialogue platform to enhance Japan's leadership position in the life science sector by fostering innovation that benefits both patients and economic growth.
Read more
The WHO Essential Medicines List (EML) is an important tool in global health and supports the achievement of the UN Sustainable Development Goals. IFPMA has published perspectives from the R&D-based industry on the utility and scope of the EML. This position paper represents IFPMA's perspective as of April 2023, ahead of the publication of the revised version of the EML.
Read moreIn a joint position paper, EFPIA, IFPMA and Vaccines Europe urge all countries to adopt a ‘multiple-site-to-one-license’ approach for registrations, in line with WHO and other guidelines. This will result in a reduction of duplicate work for all stakeholders, help to build agility and speed in supply chain management and improve patient access to medicines and vaccines.
Read moreThis month, I had the priviledge to return to Kigali, Rwanda after the launch of the State of UHC in Africa Report to witness next steps toward the delivery of health services for all. Since the report’s launch in 2021, Amref Health Africa has been working behind the scenes to develop the UHC Delivery Lab....
Read more
Explore how the innovative pharmaceutical industry is partnering to ensure innovation and access contribute to global health progress and improve lives everywhere in this report. The Sustainable Development Goals (SDGs) explicitly strive to engage the private sector in addressing the world’s most pressing challenges and emphasize the importance of cross-sector collaborations. Universal Health Coverage (UHC)...
Read more
Discover how the innovative pharmaceutical industry is embracing partnerships to accelerate action on SDG 3 and other global goals in this infographic.
Read more
This joint white paper recommends the implementation of well-designed NFC systems coupled with legislative liability protections for pandemic vaccines to ensure both equitable compensation and adequate vaccine coverage in a future pandemic.
Read moreIn a year dedicated to progressing the fight against tuberculosis — with the upcoming United Nations High-level Political Meeting — the evidence casts a bleak outlook. But there's hope.
Read more
Discover how the innovative pharmaceutical industry works with partners to advance the SDGs
Read more
On 22 March, IFPMA delivered a shortened version of the below statement at the WHO INB intersessional briefing on “Article 10: WHO Pathogen Access and Benefit Sharing System, with the Pandemic Influenza Preparedness Framework as an example” of the WHO convention, agreement, or other international instrument on pandemic prevention, preparedness, and response (“WHO CA+”).
Read more